Neoptolemos, John P. http://orcid.org/0000-0002-6201-7399
Kleeff, Jörg
Michl, Patrick
Costello, Eithne
Greenhalf, William
Palmer, Daniel H.
Article History
First Online: 1 May 2018
Competing interests
: J.P.N. reports grants from AstraZeneca, Cancer Research UK, Clovis Oncology and Ventana, Immunovia, KAEL & GemVax (Korea), Pharma Nord and Taiho Pharma (Japan); payment for lectures from Amgen and Mylan; paid consultancy from Astellas, Boehringer Ingelheim Pharma GmbH & Co KG, Erytech, KAEL & GemVax, Novartis Pharma AG, Redhill Biopharma and Tragovax; and educational travel grants from NuCana, all of which were not related to the submitted work. J.P.N. was a UK National Institute for Health Research (NIHR) senior investigator. D.H.P. reports grants from Cancer Research UK, the NIHR and NuCana and paid consultancy from NuCana. E.C. and W.G. report grants from Cancer Research UK, Immunova, the NIHR and the European Union. J.K. and P.M. declare no competing interests.